Dr. Patricia Daly is the Vice President, Public Health and Chief Medical Health Officer for Vancouver Coastal Health. She is also a Clinical Professor in the School of Population and Public Health in the Faculty of Medicine at the University of British Columbia.
As a public health physician, her primary mandate is to improve the health of the population that Vancouver Coastal Health serves through prevention and health promotion. She is responsible for communicable disease control including management of outbreaks, health protection and environmental health, community care facilities licensing, population health and public health surveillance within Vancouver Coastal Health.
Dr. Daly obtained her medical degree from the University of Toronto in 1985. She worked as a family and emergency physician in Ontario before undertaking further specialty training at McGill University and the University of Toronto. She obtained a fellowship in Community Medicine from the Royal College of Physicians and Surgeons of Canada in 1992.
After moving to Vancouver in 1993, Dr. Daly worked for two years at the BC Centre for Disease Control before moving to Vancouver/Richmond Health Board as a Medical Health Officer and Director of Communicable Disease Control. Dr. Daly continued in this role after the formation of Vancouver Coastal Health in 2001. She assumed her current position in September, 2007.
In addition to providing consultation to a wide variety of health professionals and advising the public on important public health issues, Dr. Daly also teaches medical students and residents within the Faculty of Medicine at the University of British Columbia.
External Academic/Research Representative
As Vice-Dean, Health Engagement, Dr. Michael Allard is responsible for working with the provincial health authorities, relevant health and academic organizations, and government to facilitate, coordinate and optimize academic activities and foster their integration to support the health system in B.C.
Dr. Allard completed both his undergraduate and medical degrees at UBC. Following a rotating internship at St. Michael’s Hospital in Toronto, he returned to UBC for a residency in anatomic pathology that included a research fellowship in the UBC Pulmonary Research Laboratory. He then undertook a cardiovascular research fellowship at the University of Alabama at Birmingham, returning to Vancouver in 1990. His research has focused primarily on mechanisms responsible for adaptation of the heart to exercise and hypertension. More recently, Dr. Allard has turned his attention to developing approaches to assess academic workload and to enable better integration of clinical and academic activities in pathology practice settings. Dr. Allard is a Principal Investigator in the James Hogg Research Centre and a Cardiovascular Pathologist at St. Paul’s Hospital, and he remains actively involved in educational programs at UBC.
Dr. Allard previously served as Head of the UBC Department of Pathology and Laboratory Medicine from 2009 to 2018. He is currently President of the UBC Medical Alumni Association.
As the Director, Dr. Chris Carlsten MD MPH is responsible for providing overall leadership for LAH, particularly through the development and execution of our Strategic Plan, mentoring and supervising key team members, and cultivating relationships with key stakeholders such as UBC and other academic institutions, local and provincial government leaders, non-profits including the BC Lung Association and, most importantly, patients and community advocates.
Dr. Carlsten attended undergraduate and medical school at Stanford University before training in internal, occupational, pulmonary and critical care medicine at the University of Washington. He is Professor of Medicine and Head of the Division of Respiratory Medicine at UBC, and an active respirologist with Vancouver Coast Health. He holds both the Canada Research Chair in Occupational and Environmental Lung Disease and also the Astra-Zeneca Chair in Occupational and Environmental Lung Disease at the UBC. He is the Director of the Air Pollution Exposure Laboratory, the lead for the UBC Faculty of Medicine’s Personalized Health initiative, and holds adjunct positions at the Peter Wall Institute for Advanced Studies, the UBC School of Population and Public Health and the UBC Centre for Heart Lung Innovation.
The Carlsten laboratory focuses on the respiratory and immunological health effects of inhaled environmental and occupational exposures, using diesel exhaust, western red cedar, wood smoke, and phthalates as model inhalants, in order to inform public health interventions and policy.
As Director of the Occupational Lung Disease Clinic at The Lung Centre (Vancouver General Hospital), Dr. Carlsten welcomes patients with concerns regarding occupational or environmental exposures contributing to respiratory disease — particularly asthma and COPD, but also upper airway disorders, interstitial lung disease, cancer, and pleural disease.
Dr. Carlsten is thrilled to have called Vancouver home since 2007, and is grateful to this vibrant community for fostering an unparalleled setting not only for his professional pursuits but moreover for his family and their passion for engagement within a healthy environment.
VGH & UBC Hospital Foundation
Angela has a 30-year track record of success in development, alumni relations, communications and marketing for universities and healthcare across three continents. January 1, 2020 Angela assumed the position of President & CEO, VGH & UBC Hospital Foundation, the primary philanthropic partner of Vancouver Coastal Health and one of Canada’s largest healthcare charities. Angela joined the Foundation in 2013 as the Senior Vice-President, Philanthropy, and became the Chief Development Office in 2018. Angela helped create and implement changes that resulted in a doubling of philanthropic revenues.
Prior to returning to her native Vancouver, Angela served as the Director, Advancement & Campaign, at the National University of Singapore, developing and executing Asia’s first billion-dollar fundraising campaign.
Angela has also lead development, alumni and external relations activities for the University of New South Wales Asia (Singapore), the Australian Graduate School of Management in Sydney, the Richard Ivey School of Business and the McGill Faculty of Law.
Angela serves on the Board of Directors of the Association of Fundraising Professionals (Canada), as well as the Audit & Finance Committee of GNW (Great Northern Way) Trust. She holds a BA in History & Russian from McGill University and an MBA from Université Laval.
Growing up in a household with several heavy smokers, Santa was diagnosed with asthma at the age of three. She still struggles to keep her severe asthma under control. Santa’s professional background is in business development and project management, and more recently as a project manager. She has worked internationally and locally and has a degree in psychology.
Santa is a dedicated volunteer and brings her personal and professional experience to help make things happen. Santa brings many years’ experience as a patient partner for airway health research. She also volunteers with her church and in Vancouver’s various communities. Santa is focused on building strong relationships within the CSC and cares deeply about her fellow members.
Vancouver Coastal Health Research Institute (VCHRI)
Dr. Granville is a Professor and Associate Dean, Research, VCHRI, UBC, and Executive Director, VCHRI. His early research at QLT Inc. supported the FDA approval of Visudyne® as the first treatment for age-related macular degeneration, the leading cause of blindness in the elderly. At Scripps he identified a novel therapeutic approach for reducing ischemia and reperfusion injury that led to the formation of Radical Therapeutix. Since returning to UBC, his lab has filed 32 patents that have been licensed to industry. He is also a co-Founder/CSO of viDA Therapeutics. He is currently focused on identifying therapeutic targets that contribute to aging and chronic diseases.
Dr. Joshi is responsible for functional operations at LAH including strategic planning, budgeting, reporting, partnerships, and stakeholder engagement. Prior to joining LAH, Dr. Joshi was the Managing Director of Program Operations at the Rick Hansen Institute (Praxis Spinal Cord Institute) where he was responsible for strategic and operational planning, reporting, performance evaluation, risk management, and regulatory compliance related to translational research and best practice implementation. Dr. Joshi received his Ph.D. in Biochemistry from the University of British Columbia and has published in diverse areas including genomics, gene therapy, drug discovery, and parasitology across several positions in academia and industry. Dr. Joshi has a passion for promoting and ensuring impact of research on patients and priority populations through collaborations and inclusion of diverse perspectives and voices.
External Academic/Research Representative
Dr. Darryl Knight joined Providence Health Care as Vice-President, Research and Academic Affairs in 2019. His role also includes accountabilities as President, Providence Health Care Research Institute; Professor, Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia; and Associate Dean, Research, Faculty of Medicine, UBC. Dr. Knight obtained his PhD from the University of Western Australia in 1993. In 2004, he was recruited to UBC as the Canada Research Chair in Airway Disease. He was recruited back to Australia in 2013 and was Professor and Head of School of Biomedical Sciences and Pharmacy at the University of Newcastle. Continuing this pattern, Dr. Knight was recruited back to Canada in 2019 taking up his current role.
Dr. Knight is a cell biologist with an international reputation in the area of lung and airway remodelling. His research career has focused on understanding how abnormal epithelial cell-fibroblast interactions influence the severity and chronicity of respiratory diseases. To date, he has published over 166 peer-reviewed manuscripts and book chapters (h-factor 55; 9120 citations – Google Scholar, May 2019).
Dr. Knight has a strong track record of obtaining research grant funding (>$20 million), including leading a successful application for $7 million from the CFI in 2012. He is regularly invited to present his work and chair sessions at major national and international meetings.
Dr. Knight has strong research leadership credentials. From 2009-2012 he was the Associate Director of the UBC James Hogg Research Centre and sat on the executive of the Institute for Heart and Lung Health. He sits on several national and international scientific research committees, and is on the editorial board of 5 international journals. Dr. Knight has been primary supervisor for 7 Post-doctoral fellows, 17 PhD and 2 MSc students and over 18 Graduate students.
External Academic/Research Representative
Dr. Montaner received his MD with Honours in 1979 at the University of Buenos Aires, Argentina. In 1981, he joined the University of British Columbia as a post-doctoral fellow, completed a residency in Internal Medicine and Respiratory Medicine and was Chief Resident for the Department of Medicine in 1986/1987.
In 1987 Dr. Montaner joined the Faculty at St. Paul’s Hospital/University of British Columbia as the Director of the AIDS Research Program and the Infectious Disease Clinic. He held a National Health Research Scholar of Health Canada (NHRDP) for a period of 10 years starting in 1988. He is a founding co-Director of the Canadian HIV Trials Network. He has held the Endowed Chair on AIDS Research at SPH/UBC since 1996. In 1997, he was appointed Professor of Medicine at UBC. He is the Director of the BC Centre for Excellence in HIV/AIDS. He was the President of the International AIDS Society from 2008-2010 and currently is the Local Co-Chair of the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention which will be held in Vancouver July 19-22, 2015. Recently, he has been assigned the position of Global Advisor on HIV Therapeutics to the Executive Director of the United Nations AIDS Programme.
Dr. Montaner has authored over 800 scientific publications on HIV/AIDS. He has focused his research in the development of antiretroviral therapies and management strategies. In the mid 90’s, as the PI of the INCAS Trial, he played a key role in establishing the efficacy of NNRTI based highly active antiretroviral therapy (HAART), which emerged as the new global Standard of Care at the 1996 Vancouver International AIDS Conference, of which he was a co-organizer. He then focused his attention to HAART access to hard to reach populations, including injection drug users, and the treatment of multiple drug resistant HIV infection with great success. Since the late 90’s he also pioneered the concept of Treatment as Prevention® (TasP® ). He was the first to advocate for the expansion of HAART coverage to curb the impact of the HIV/AIDS pandemic, in terms of decreasing progression to AIDS and death, as well as decreasing HIV transmission. Largely through his efforts, TasP® has now been implemented with great success in BC, and progressively embraced by UNAIDS, China, PEPfAR, the US Government, and France, among others. In 2013 TasP® was fully incorporated in the WHO Consolidated ARV Guidelines.
Dr. Montaner has received numerous awards and distinctions for his research work, among them the Knowledge Translation Award from the Canadian Institutes of Health (CIHR), Prix Galien Award, Albert Einstein World of Science Award, Hope is a Vaccine Award from the Global Alliance to Immunize against AIDS, and the David Barry DART Achievement Award that is given in recognition of invaluable contributions to the field of HIV drug discovery. He has received the Grand Decoration of Honour for Services to Austria, The Queen Elizabeth II Diamond Jubilee Medal for contributions to the field of HIV/AIDS, “Senador Domingo Faustino Sarmiento” from the Argentina Senate of the Nation presented to him by the Honorable Amado Boudou, Vice President of Argentina, and the Honorable Maria Laura Leguizamon, Senator of Buenos Aires, three Doctor of Science honoris causa degrees from Simon Fraser University, Cordoba University and the University of Buenos Aires, and an honorary fellow at Douglas College. He is a Member of the Order of British Columbia and an Officer of the Order of Canada. He has been inducted into the Royal Society of Canada-The Academies of Arts, Humanities and Sciences (RSC) and into the Canadian Medical Hall of Fame.
VGH Clinical Care Representative
Carmen Rempel is a Respiratory Therapist and Certified Respiratory Educator at Vancouver General Hospital (VGH) in British Columbia (BC), Canada. She is currently part of the VGH COPD Transition Team that provides intensive case-management and post-hospital care in patients admitted with acute exacerbation of COPD. Prior to this role she was the Airways Educator at VGH providing self-management counseling for asthma, allergy and COPD patients and their families.
Carmen has worked in a variety of areas of Respiratory Therapy including, critical care, ward therapy, supervisory, and pulmonary diagnostics. She is an instructor in the BC Spirometry program with RespTrec®: a Canadian Respiratory Training and Educator Course.
Carmen is a volunteer with the international program GASP: Global Access to Spirometry Project. The project delivers education, training, and support in low-resource settings in South America to nurses and physicians to enable them to diagnose, treat and educate people with COPD and asthma.
Public / Patient Representative
I am a Health Sciences College Educator and former Nurse Practitioner and Natural Health Practitioner. I have experience working in rural and remote areas (Nunavut) and in a variety of settings and diverse cultures.
My lived experience with chronic respiratory illness, chronic nerve pain (after a sports injury and delayed surgery), and as a cancer survivor, taught me the importance of being an informed patient and an equal partner in health care and decision-making. I was a long-time volunteer facilitator and Health Coach for UVic’s self-management programs and still am a “First Link” Peer Support for the Leukemia and Lymphoma Society.
My engagement with the BC SUPPORT Unit and CIHR started as a co-facilitator for the CIHR pilot program for SPOR and later publication of “Co-building a patient-oriented research curriculum.” My interest is in advancing health research; improving health outcomes; and achieving equity, diversity, and inclusion for all. Besides the CSC, I am also a member of Clinical Trials BC and the BC SUPPORT Unit Advisory Council, and co-chair of the Provincial Patient Council.
VGH Clinical Care Representative
Dr. Nardia Strydom has been working as a family physician in BC for the last 25 years and loves her job! She enjoys the variety and unexpected nature of family medicine, the connections with her patients, and the comprehensive long-term care she can provide. As a “full-service family physician” her patients are newborns, seniors, and everything in-between. Nardia is a teacher and a learner and is stimulated by change and its possibilities. She is the Department Head of Family Medicine at Providence Health Care, Regional Department Head of Family Medicine, Vancouver Coastal Health and Providence Health Care and Regional Medical Director of Primary Care for Vancouver Coastal Health. Her family, friends, gardening, exercise and anything to do with food keep her life in balance.